Rockefeller Capital Management
YTEN

Rockefeller Capital Management’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Rockefeller Capital Management’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-23
Closed -$7K – 3645
2021
Q1 		$7K Buy
+23
New +$7.78K ﹤0.01% 2797

Other funds holding YTEN

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Rockefeller Capital Management's YTEN Position: Q2 2021 in Review

Rockefeller Capital Management sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2021, closing a stake of 23 shares — an estimated $7K sold.

Rockefeller Capital Management first reported a position in YTEN in Q1 2021 and held it in 1 quarter. The position peaked at $7K in Q1 2021. 19 funds tracked by Wall St. Rank hold YTEN as of Q2 2021.

  • Rockefeller Capital Management reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Rockefeller Capital Management sold 23 Yield10 Bioscience, Inc. Common Stock shares in Q2 2021, an estimated $7K.
  • Rockefeller Capital Management first reported a position in Yield10 Bioscience, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Rockefeller Capital Management's Yield10 Bioscience, Inc. Common Stock position peaked at $7K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2021.

Based on Rockefeller Capital Management's 13F filing for Q2 2021, filed 10 Aug 2021.